Brian Callaghan

Summary

Affiliation: University of Michigan
Country: USA

Publications

  1. ncbi The association of exposure to lead, mercury, and selenium and the development of amyotrophic lateral sclerosis and the epigenetic implications
    Brian Callaghan
    University of Michigan, Ann Arbor, MI 48109, USA
    Neurodegener Dis 8:1-8. 2011
  2. ncbi Capturing cases of distal symmetric polyneuropathy in a community
    Brian Callaghan
    Department of Neurology, University of Michigan, 109 Zina Pitcher Place, 4021 BSRB, Ann Arbor, Michigan 48104, USA
    Muscle Nerve 46:943-7. 2012
  3. ncbi Diabetic neuropathy: clinical manifestations and current treatments
    Brian C Callaghan
    University of Michigan, Ann Arbor, MI, USA
    Lancet Neurol 11:521-34. 2012
  4. ncbi Enhanced glucose control for preventing and treating diabetic neuropathy
    Brian C Callaghan
    Department of Neurology, University ofMichigan, Ann Arbor, Michigan, USA
    Cochrane Database Syst Rev 6:CD007543. 2012
  5. ncbi The evaluation of distal symmetric polyneuropathy: a physician survey of clinical practice
    Brian C Callaghan
    Department of Neurology, University of Michigan, 109 Zina Pitcher Place, Ann Arbor, MI 48104, USA
    Arch Neurol 69:339-45. 2012
  6. ncbi Remission and relapse in a drug-resistant epilepsy population followed prospectively
    Brian Callaghan
    University of Michigan, Ann Arbor, Michigan, USA
    Epilepsia 52:619-26. 2011
  7. ncbi Triglycerides and amputation risk in patients with diabetes: ten-year follow-up in the DISTANCE study
    Brian C Callaghan
    University of Michigan, Ann Arbor, Michigan, USA
    Diabetes Care 34:635-40. 2011
  8. ncbi Tests and expenditures in the initial evaluation of peripheral neuropathy
    Brian Callaghan
    Department of Neurology, University of Michigan, Ann Arbor, MI 48104, USA
    Arch Intern Med 172:127-32. 2012

Detail Information

Publications8

  1. ncbi The association of exposure to lead, mercury, and selenium and the development of amyotrophic lateral sclerosis and the epigenetic implications
    Brian Callaghan
    University of Michigan, Ann Arbor, MI 48109, USA
    Neurodegener Dis 8:1-8. 2011
    ..Perhaps an interaction between the metal exposure and an individual's genetic makeup is required to produce epigenetic changes that ultimately lead to ALS...
  2. ncbi Capturing cases of distal symmetric polyneuropathy in a community
    Brian Callaghan
    Department of Neurology, University of Michigan, 109 Zina Pitcher Place, 4021 BSRB, Ann Arbor, Michigan 48104, USA
    Muscle Nerve 46:943-7. 2012
    ..Little is known about what constitutes appropriate diagnostic testing in patients with distal symmetric polyneuropathy (DSP)...
  3. ncbi Diabetic neuropathy: clinical manifestations and current treatments
    Brian C Callaghan
    University of Michigan, Ann Arbor, MI, USA
    Lancet Neurol 11:521-34. 2012
    ..Studies are needed to further explore this association, which has implications for the development of new treatments for this common disorder...
  4. ncbi Enhanced glucose control for preventing and treating diabetic neuropathy
    Brian C Callaghan
    Department of Neurology, University ofMichigan, Ann Arbor, Michigan, USA
    Cochrane Database Syst Rev 6:CD007543. 2012
    ..Enhanced glucose control is the best studied intervention for the prevention of this disabling condition but there have been no systematic reviews of the evidence...
  5. ncbi The evaluation of distal symmetric polyneuropathy: a physician survey of clinical practice
    Brian C Callaghan
    Department of Neurology, University of Michigan, 109 Zina Pitcher Place, Ann Arbor, MI 48104, USA
    Arch Neurol 69:339-45. 2012
    ..To define current clinical practice for evaluating distal symmetric polyneuropathy...
  6. ncbi Remission and relapse in a drug-resistant epilepsy population followed prospectively
    Brian Callaghan
    University of Michigan, Ann Arbor, Michigan, USA
    Epilepsia 52:619-26. 2011
    ..In addition, we determined clinical predictors of remission and relapse in this population...
  7. ncbi Triglycerides and amputation risk in patients with diabetes: ten-year follow-up in the DISTANCE study
    Brian C Callaghan
    University of Michigan, Ann Arbor, Michigan, USA
    Diabetes Care 34:635-40. 2011
    ..To determine the association between triglyceride levels and lower-extremity amputation (LEA) risk in a large diabetic cohort...
  8. ncbi Tests and expenditures in the initial evaluation of peripheral neuropathy
    Brian Callaghan
    Department of Neurology, University of Michigan, Ann Arbor, MI 48104, USA
    Arch Intern Med 172:127-32. 2012
    ..Peripheral neuropathy is a common disorder in which an extensive evaluation is often unrevealing...